GENE ONLINE|News &
Opinion
Blog

Bora Pharmaceuticals
Bora Pharmaceuticals Acquires 30.5% Stake in Tanvex Biopharma, Becomes Largest Corporate Shareholder
2024-08-28
BIO 2024 Showcases the Emergence of Taiwan’s Biotech CDMO Market
2024-06-04
JPM 2024: Taiwan’s Pharma Giant Bora Pharmaceuticals Climbing US Pharmaceutical Summit
2024-01-10
Bora and Celltrion Join Forces To Distribute Oral Drugs Across APAC
2023-04-07
Bora Pharmaceuticals Expands with Eden Biologics’ CDMO Purchase
2022-05-11
The 8 Companies Propelling Taiwan’s Biopharma Industry
2021-10-21
Japan’s Kyowa Inks Deal with Taiwan’s CDMO Firm to Manufacture Generic Drugs
2021-08-06
Weekly Cover: Takeda Initiates Development of Potential COVID-19 Therapy TAK-888
2020-03-13
LATEST
Donald Trump’s “Most Favored Nation” Executive Order on Drug Pricing
2025-05-12
Discover Investment Opportunities & Innovation at International Healthcare Week in Hong Kong from May
2025-05-12
The Buffett Paradox: Cola, Happiness, and a Biotech Longevity Enigma
2025-05-11
President to Sign Executive Order on Trade Enforcement Monday Morning
2025-05-11
Trump to Sign Executive Order Linking U.S. Drug Prices to International Levels.
2025-05-11
Podcast Highlights Agile Biopharmaceutical Firms’ Strategies for Navigating Complex Clinical Trials
2025-05-11
New Mask Detects Chronic Kidney Disease in 84% of Tested Cases
2025-05-11
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top